![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
NR Bachur, F Yu, R Johnson, R Hickey, Y Wu and L Malkas
Department of Medicine, University of Maryland Cancer Center, Baltimore 21201.
Helicases are essential to both DNA replication and transcription because they separate double-stranded DNA, preparing the single strands for replication or transcription. Because the anti-cancer anthracycline antibiotics stabilize double-stranded DNA primarily by their intercalative binding, we expected the intercalated antibiotics to interfere with helicase action. We examined anthracycline antibiotic effects on SV40 large T antigen helicase activity, using a duplex DNA helicase substrate of 32P-labeled 17-mer annealed to complementary M13mp19(+) circular single-stranded DNA. The T antigen helicase activity was potently inhibited by the anthracycline antibiotics. The T antigen helicase IC50 values for the anthracycline antibiotics were as follows: nogalamycin, 2 x 10(-7) M; daunorubicin, 4 x 10(-7) M; doxorubicin, 4 x 10(-7) M; idarubicin, 1.8 x 10(-6) M; 4'- epidoxorubicin, 2 x 10(-6) M; aclacinomycin, 4 x 10(-6) M; and menogaril, 6 x 10(-6) M. Partially purified helicases from HeLa cells and murine mammary carcinoma FM3A cells also were potently inhibited by doxorubicin, with IC50 values of 4 x 10(-7) M and 9 x 10(-7) M, respectively. Because the abundance, specificities, and types of helicases vary in the cell, this site of action for anthracycline antibiotics may help explain anthracycline potency, drug specificity for DNA or RNA inhibition, and some types of cellular resistance to these drugs.
This article has been cited by other articles:
|
|
 |
|
  R. S. Huang, S. Duan, E. O. Kistner, W. K. Bleibel, S. M. Delaney, D. L. Fackenthal, S. Das, and M. E. Dolan Genetic Variants Contributing to Daunorubicin-Induced Cytotoxicity Cancer Res., May 1, 2008; 68(9): 3161 - 3168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Duan, W. K. Bleibel, R. S. Huang, S. J. Shukla, X. Wu, J. A. Badner, and M. E. Dolan Mapping Genes that Contribute to Daunorubicin-Induced Cytotoxicity Cancer Res., June 1, 2007; 67(11): 5425 - 5433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Furuchi, T. Takahashi, S. Tanaka, K. Nitta, and A. Naganuma Functions of yeast helicase Ssl2p that are essential for viability are also involved in protection from the toxicity of adriamycin Nucleic Acids Res., May 11, 2004; 32(8): 2578 - 2585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tuteja Plant DNA helicases: the long unwinding road J. Exp. Bot., October 1, 2003; 54(391): 2201 - 2214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nakamura, H. Sugumi, A. Yamaguchi, T. Uenaka, Y. Kotake, T. Okada, J. Kamata, J. Niijima, T. Nagasu, N. Koyanagi, et al. Antitumor Activity of ER-37328, a Novel Carbazole Topoisomerase II Inhibitor Mol. Cancer Ther., January 1, 2002; 1(3): 169 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Xu, F. Hamhouyia, S. D. Thomas, T. J. Burke, A. C. Girvan, W. G. McGregor, J. O. Trent, D. M. Miller, and P. J. Bates Inhibition of DNA Replication and Induction of S Phase Cell Cycle Arrest by G-rich Oligonucleotides J. Biol. Chem., November 9, 2001; 276(46): 43221 - 43230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Tuteja and T.-N. Phan A Chloroplast DNA Helicase II from Pea That Prefers Fork-Like Replication Structures Plant Physiology, November 1, 1998; 118(3): 1029 - 1038. [Abstract] [Full Text]
|
|
|
|
|
|
E. D. Larson and J. T. Drummond Human Mismatch Repair and G{middle dot}T Mismatch Binding by hMutSalpha in Vitro Is Inhibited by Adriamycin, Actinomycin D, and Nogalamycin J. Biol. Chem., March 23, 2001; 276(13): 9775 - 9783. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
